PropertyValue
?:abstract
  • OBJECTIVE: We examined the qualitative impact of an online integrative oncology (IO) treatment program, designed in response to the restrictions created by the current COVID-19 pandemic. METHODS: Patients undergoing chemotherapy were seen by an integrative physician (IP), together co-designing an IO treatment program of ≥ 6 weekly treatments to alleviate symptoms and improve quality of life (QoL). IO practitioners guided patients and their caregivers online in self-treatment with manual/touch, movement, and/or mind-body modalities. Narratives of both patients and IO practitioners were analyzed for systematic coding, identifying barriers and advantages of the online treatment program. RESULTS: Narratives obtained from 30 patients and eight IO-trained practitioners were examined. The patients had undergone 169 online IO sessions with a total of 327 IO interventions during the 3-month study period. Patient narratives included reflections on both non-specific effects (e.g., less of a “sense of isolation”) and specific QoL-related outcomes with the online intervention. IO practitioner narratives focused on barriers to providing manual-movement and mind-body modalities, suggesting practical recommendations on how to address specific QoL-related outcomes using the online IO “toolbox.” CONCLUSIONS: Effective online IO practitioner-guided treatments are feasible and may induce both specific and non-specific QoL-related effects. Future research needs to explore online IO interventions for additional situations in which access to IO care is limited.
?:creator
?:doi
  • 10.1007/s00520-021-06026-x
?:doi
?:journal
  • Support_Care_Cancer
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/8bb4ba8dcf207be843076b08f98a7572e5ac59da.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7859467.xml.json
?:pmcid
?:pmid
?:pmid
  • 33538895.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Being in touch: narrative assessment of patients receiving online integrative oncology treatments during COVID-19
?:type
?:year
  • 2021-02-04

Metadata

Anon_0  
expand all